Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Irish medical device outsourcer Creganna-Tactx Medical said today that it agreed to acquire Precision Wire Components LLC for an unspecified amount, saying it will re-brand as Creganna Medical.
The deal includes PWC’s manufacturing plants in Tualatin, Ore., and Heredia, Costa Rica, according to a press release. Read more
Medtronic and Covidien said yesterday that their pending, $43 billion merger is slated to close in early 2015.
The companies said the timeline is based on their need to finalize the joint proxy statement and prospectus, win approval from regulators and shareholders and then win the favor of the Irish High Court. Covidien’s corporate domicile is Ireland, although the company is run from its Mansfield, Mass., headquarters. Read more
Aethlon Medical said that it plans to make its Hemopurifier blood-filtration device available to U.S. healthcare providers for the treatment of Ebola under the FDA’s compassionate use provision.
“Based on guidance from FDA, the treatment of Ebola virus infection provides for a unique circumstance where a physician or healthcare provider may wish to pursue the compassionate use of Hemopurifier therapy based on the serious nature of the disease and absence of alternative therapies,” according to a press release. Read more